Related Experiment Video
Updated: Jun 8, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Fetuin-mineral complex reflects extraosseous calcification stress in CKD
Takayuki Hamano1, Isao Matsui, Satoshi Mikami
1Department of Geriatric Medicine and Nephrology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan. hamatea@medone.med.osaka-u.ac.jp
Fetuin-mineral complex (FMC) in CKD patients, not just fetuin-A levels, reflects calcification risk. Measuring FMC offers a better indicator of extraosseous calcification stress in chronic kidney disease.
Area of Science:
- Nephrology
- Biochemistry
- Cardiovascular Medicine
Background:
- Fetuin-A inhibits extraosseous calcification, but its role in vascular calcification in chronic kidney disease (CKD) is debated.
- Previous ELISA studies found no significant link between serum fetuin-A and vascular calcification in CKD patients.
Purpose of the Study:
- To investigate the role of a fetuin-mineral complex (FMC) in vascular calcification in CKD patients.
- To determine if FMC, rather than serum fetuin-A, correlates with calcification burden.
Main Methods:
- Serum separation via centrifugation to isolate FMC (fetuin-A, fibrinogen, fibronectin-1, calcium).
- Analysis of serum and supernatant fetuin-A levels in CKD patients (hemodialysis and predialysis).
- Correlation analysis with coronary artery calcification scores (CACS) and longitudinal study of treatment effects.
Main Results:
- FMC circulates systemically in CKD patients, with increased contribution to total fetuin-A as CKD severity progresses.
- Supernatant fetuin-A negatively correlated with CACS, while the reduction ratio (RR) of fetuin-A positively correlated with CACS.
- Treatments like parathyroidectomy and cinacalcet reduced RR, indicating decreased FMC, without altering supernatant fetuin-A.
Conclusions:
- Quantitative measurement of FMC, not serum or supernatant fetuin-A, better reflects extraosseous calcification stress in CKD.
- FMC is a more accurate biomarker for vascular calcification risk in CKD patients.
More Related Videos
08:43Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
14:55Analysis of Minerals Produced by hFOB 1.19 and Saos-2 Cells Using Transmission Electron Microscopy with Energy Dispersive X-ray Microanalysis
Published on: June 24, 2018
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Skeleton and Calcium Homeostasis
Chronic Kidney Disease III: Interprofessional Care
Roles of Electrolytes: Calcium and Phosphate
The calcium concentration in blood plasma is primarily regulated...
Chronic Kidney Disease I: Introduction